SunTrust Robinson Humphrey Downgrades Juno Therapeutics (JUNO) to Hold

November 25, 2016 6:48 AM EST
Get Alerts JUNO Hot Sheet
Price: $20.00 --0%

Rating Summary:
    8 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 29 | Down: 28 | New: 6
Trade JUNO Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

SunTrust Robinson Humphrey downgraded Juno Therapeutics (NASDAQ: JUNO) from Buy to Hold with a price target of $25.00 (from $48.00) after the ROCKET study evaluating JCAR015 in no-option Adult ALL was placed on clinical hold for the second time.

The analyst sees reduced visibility and increased uncertainty, and have conservatively removed ALL from the model.

For an analyst ratings summary and ratings history on Juno Therapeutics click here. For more ratings news on Juno Therapeutics click here.

Shares of Juno Therapeutics closed at $22.56 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Downgrades

Related Entities

SunTrust Robinson Humphrey

Add Your Comment